Biomarkers play a crucial role in prognostication of HFpEF, a syndrome that displays sex differences and is intertwined with atrial fibrillation. We’ve discussed about challenges in HFpEF with Carolyn S. P. Lam (National Heart Centre Singapore, Duke-NUS Medical School, Singapore) during the ESC Congress in Munich.